Compare First Solar, Inc. (FSLR) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Solar, Inc. vs Novartis AG — how do they compare? First Solar, Inc. trades at $211.65 (market cap $24.05B), while Novartis AG trades at $152.75 (market cap $287.66B). The key difference: Novartis AG is far larger — about 12× First Solar, Inc.'s market cap, and Novartis AG pays a 3.14% dividend while First Solar, Inc. pays none. Which is the better fit depends on your goals.
| FSLR | NVS | |
|---|---|---|
Market Cap | $24.05B | $287.66B |
Sector | Technology | Health |
52-Week High | $318.30 | $168.62 |
52-Week Low | $166.82 | $113.50 |
Enterprise Value | $22.21B | $327.68B |
Dividend Yield | — | 3.14% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About First Solar, Inc.
First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and a new factory under construction in India.
Read more on FSLR →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
